Posted Mar. 13, 2012 at 1:03 p.m.

Premium Lock Raleigh-based Salix Pharmaceuticals to raise $600M

Published: 2012-03-13 13:03:45
Updated: 2012-03-13 13:03:45

Salix Salix

Salix says it will repurchase outstanding convertible senior notes that are due in 2028. The company also plans to repurchase up to $75 million of its outstanding common stock and will also use proceeds for corporate purposes....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders